Nx Pharmagen reported raising $590,000 in an initial SEC Form D filing, from an offering of $1 Million
Round Type
Seed
LouisvilleBiotechnologyQuick answer
NXPharmagen raised $590,000 in a Seed round, dated October 10, 2022. NXPharmagen is based in Louisville, Kentucky, United States.
- How much did NXPharmagen raise?
- NXPharmagen raised $590,000 in a Seed round on October 10, 2022.
- What does NXPharmagen do?
- NX PharmaGen Inc. was founded to invest in technologies that have the potential to enrich the lives of patients.
- Where is NXPharmagen based and how big is it?
- NXPharmagen is based in Louisville, Kentucky, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as NXPharmagen that raised within 45 days of this round, from Fundz verified event records.
- Hemispherian AS raised an undisclosed amount (Series A) on November 24, 2022.
- Secretome Therapeutics raised $6.9M on November 23, 2022.
- Nyra Medical raised $20M (Series A) on November 23, 2022.
- Kiyatec Inc. raised $18M on November 23, 2022.
- CatalYm raised $51M (Series C) on November 22, 2022.
- Empatica raised an undisclosed amount (Series B) on November 22, 2022.
Who to call at NXPharmagen, and when
A new round usually means NXPharmagen is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NXPharmagen raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NXPharmagen, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NXPharmagen. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NXPharmagen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
NXPharmagen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.